title: Sweet syndrome presenting as resistant conjunctivitis.
abstract: OBJECTIVE
  We report a patient with chronic Sweet syndrome (SS) treated by anti-Tumor Necrosis Factor (TNF) therapy, who presented with a severe bilateral chemosis.
  
  
  METHODS
  Case report.
  
  
  RESULTS
  Conjunctival biopsy revealed an ocular localization of SS.
  
  
  CONCLUSIONS
  SS is a rare disorder that usually affects middle-age women. It is characterized by an acute febrile neutrophilic dermatosis. To our knowledge, this is the first documented case of an ocular localization in SS and the first report of a severe bilateral chemosis as ocular manifestation.
authors.affiliation: Department of Ophthalmology, Strasbourg University Hospital, Louis Pasteur University, Strasbourg, France. g67michel@yahoo.fr
authors.forename: Guillaume
authors.initials: G
authors.lastname: Michel
authors.forename: Benoist
authors.initials: B
authors.lastname: Lhermitte
authors.forename: Bernard
authors.initials: B
authors.lastname: Cribier
authors.forename: Claude
authors.initials: C
authors.lastname: Speeg-Schatz
authors.forename: Tristan
authors.initials: T
authors.lastname: Bourcier
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D003228:Conjunctiva / Q000098:blood supply / Q000473:pathology; D003229:Conjunctival Diseases / Q000209:etiology* / Q000473:pathology; D003231:Conjunctivitis / Q000209:etiology*; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000209:etiology* / Q000473:pathology; D006801:Humans; D006940:Hyperemia / Q000209:etiology; D000069285:Infliximab; D008297:Male; D012008:Recurrence; D016463:Sweet Syndrome / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D000069285:Infliximab